atorvastatin has been researched along with Degenerative Disc Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, W; Huang, Z; Li, J; Li, S; Xu, K; Yan, J; Ye, W; Yuan, L; Zhang, Y; Zhou, J; Zhu, J | 1 |
| Aboosaeedi, HR; Eskandari, M; Eskandary, H; Karamouzian, S; Malekpoor-Afshar, R; Reihani-Kermani, H; Saeed, A; Safizade, H | 1 |
2 other study(ies) available for atorvastatin and Degenerative Disc Disease
| Article | Year |
|---|---|
Atorvastatin inhibited TNF-α induced matrix degradation in rat nucleus pulposus cells by suppressing NLRP3 inflammasome activity and inducing autophagy through NF-κB signaling.
Topics: Animals; Atorvastatin; Autophagy; Inflammasomes; Intervertebral Disc Degeneration; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Nucleus Pulposus; Rats; Signal Transduction; Tumor Necrosis Factor-alpha | 2021 |
Effect of atorvastatin on angiogenesis in degenerated intervertebral disc in rat.
Topics: Angiogenesis Inducing Agents; Animals; Atorvastatin; Biomarkers; Disease Models, Animal; Heptanoic Acids; Immunohistochemistry; Intervertebral Disc; Intervertebral Disc Degeneration; Male; Neovascularization, Physiologic; Pyrroles; Rats; Rats, Wistar; Time Factors; von Willebrand Factor | 2011 |